J. Rosenstock

Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood.

P. H. Jones, S. Shalet, D. Pearson, 1977, Clinical radiology.

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study

J. McGill, J. Rosenstock, I. Hramiak, 2009, Diabetologia.

Basal Insulin Glargine (HOE 901) versus NPH Insulin in Patients With Type 1 Diabetes on Multiple Daily Insulin Regimes

G. Park, J. Rosenstock, J. Zimmerman, 2001 .

Effect of glycemic control on microvascular complications in patients with type I diabetes mellitus.

P. Raskin, T. Friberg, J. Rosenstock, 1986, The American journal of medicine.

Diabetes and its complications: blood glucose control vs. genetic susceptibility.

P. Raskin, J. Rosenstock, P Raskin, 1988, Diabetes/metabolism reviews.

The effect of long-term near normal glycemic control on mild diabetic retinopathy.

P. Raskin, G. Sanborn, T. Friberg, 1985, Ophthalmology.

Blood glucose control and diabetic complications.

P. Raskin, J. Rosenstock, J. Rosenstock, 1986, Annals of internal medicine.

The effect of the aldose reductase inhibitor, ponalrestat, on the progression of diabetic retinopathy.

C. Arauz-Pacheco, J. Rosenstock, Lourdes Pruneda, 1992, Journal of diabetes and its complications.

Relationship between lipoprotein levels and in vivo insulin action in normal young white men.

P. Raskin, J. Rosenstock, A. Garg, 1988, Metabolism: clinical and experimental.